Epstein Secrets

izer-s-covid-vaccine-trial-plan-may-beat- rivals-to-early-look?smd=premium> (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first look

rmation Online. The New York Times <https://www.nytimes.com/2020/09/22/technology/this-misinformation-was-coming-from- inside-the-house.html> (9/22, Montague, 18.61M) reports that the former public affairs officer at the National Institutes of Health who "abruptly retired" as The Daily Beast "prepared to

n people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first loo

ts, is behind the latest testing issue. NIH Official Exits After It Is Revealed He Published COVID Misinformation Online. The New York Times (9/22, Montague, 18.61M) reports that the former public affairs officer at the National Institutes of Health who "abruptly retired" as The Daily Beast "prepared to

n people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first loo

ts, is behind the latest testing issue. NIH Official Exits After It Is Revealed He Published COVID Misinformation Online. The New York Times (9/22, Montague, 18.61M) reports that the former public affairs officer at the National Institutes of Health who "abruptly retired" as The Daily Beast "prepared to